Good read, thanks. SPL continues to tick all the right boxes. I think the fact that it's Australian and listed on the ASX keeps it under the radar, but it's only a matter of time before this stock is worth $10+ a share. Maybe this time next year? Personally I think they we will bought out before then, once the data starts to come in for phase 2 DEP DOC, and the FDA approval comes through for VivaGel. Hopefully it will spark a bidding war.
Very interesting article, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.4¢ |
Change
-0.001(1.05%) |
Mkt cap ! $39.23M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 9.7¢ | 9.4¢ | $8.719K | 91.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 299527 | 9.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |